Business Context and Reporting Period
This Form 8-K was filed by AEye, Inc. on July 20, 2023. The report addresses a regulatory matter concerning the continued listing of the Company's common stock (trading symbol: LIDR) and warrants (LIDRW) on The Nasdaq Capital Market.
Key Financial Metrics
This filing is a current report regarding corporate governance and listing status. It does not provide financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics.
Material Changes and Listing Status
- Non-Compliance: The Company failed to meet Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 for 30 consecutive business days.
- First Compliance Period: The initial 180-day period to regain compliance expired on July 19, 2023, without the Company meeting the requirement.
- Second Compliance Period: On July 20, 2023, Nasdaq granted the Company a second 180-day compliance period, extending until January 16, 2024.
- Current Status: The Company's stock remains listed on Nasdaq under the symbol "LIDR" during this second compliance period.
Outlook, Risks, and Management Commentary
- Delisting Risk: If the Company fails to regain compliance by the Second Compliance Date (January 16, 2024), Nasdaq is expected to notify the Company of a determination to delist its common stock.
- Appeal Process: In the event of a delisting determination, the Company may appeal to a Nasdaq hearings panel.
- Remediation Options: Management stated it will consider available options to resolve the deficiency, including implementing a reverse stock split of its outstanding securities.
- Uncertainty: The filing explicitly states there can be no assurance that the Company will regain compliance, succeed in any appeal, or maintain compliance with other Nasdaq listing requirements.
Investor Verification Checklist
- Verify the current closing bid price of LIDR to assess proximity to the $1.00 threshold.
- Monitor future filings for announcements regarding a potential reverse stock split.
- Track the Company's progress toward the January 16, 2024, deadline to avoid delisting.
- Review the Company's most recent 10-Q or 10-K for financial health metrics not included in this 8-K.